JPMP CAPITAL CORP.

CIK 1330534 · last filed 2015-02-25

JPMP CAPITAL CORP. is a corporate insider who has filed 4 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing shows the insider sold $2.15B of ARMK on Feb 25, 2015. Across all open-market trades the lifetime net is −$2.24B, making them a net seller over the disclosed history. Current disclosed insider exposure totals $11.7M across reported positions. The firm reports its address in New York, NY. 59 SEC filings were submitted jointly with JPMP MASTER FUND MANAGER L P.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$11.75M

Companies

4

Total Filings

4

Lifetime Open-Market Net

-$2.24B

Filer Profile

Reported Address

270 PARK AVENUE
10TH FLOOR
NEW YORK, NY 10017

Phone

(212) 648-1100

Formerly Known As

J.P. Morgan Partners, LLC (2013–2013)

JPMP CAPITAL CORP (2005–2013)

Related Filers

JPMP MASTER FUND MANAGER L P — 59 joint filings, latest 2015-03-27

JP MORGAN PARTNERS BHCA LP — 50 joint filings, latest 2015-03-27

GLOBAL INVESTORS L P JPMP — 38 joint filings, latest 2015-03-27

J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN II LP — 36 joint filings, latest 2015-03-27

JP MORGAN PARTNERS GLOBAL INVESTORS LP — 35 joint filings, latest 2015-03-27

J P MORGAN PARTNERS GLOBAL INVESTORS A LP — 33 joint filings, latest 2015-03-27

JP MORGAN PARTNERS GLOBAL INVESTORS SELLDOWN LP — 32 joint filings, latest 2015-03-27

JP MORGAN PARTNERS GLOBAL INVESTORS SELLDOWN II L P — 17 joint filings, latest 2015-03-27

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
ARMK	10%+ Owner	200,656	$58.55	$11.75M	-$2.15B	1	2015-02-25
PHARMOS CORP (PARS) Delisted	10%+ Owner	664	—	—	$0	1	2008-01-25
Seagen Inc. (SGEN) Delisted	10%+ Owner	2,295,640	$228.74	$525.10M	$0	1	2007-07-12
BARRIER THERAPEUTICS INC (BTRX) Delisted	10%+ Owner	2,174,332	—	—	-$81.07M	1	2007-06-08

Recent Filings

4 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2015-02-25	ARMK	Sell (S)	−72,117,300	-$2.15B	EDGAR
2008-01-25	PHARMOS CORP (PARS) Delisted	Grant (A)	—	$0	EDGAR
2007-07-12	Seagen Inc. (SGEN) Delisted	Conv (C)	+31,395,000	$0	EDGAR
2007-06-08	BARRIER THERAPEUTICS INC (BTRX) Delisted	Sell (S)	−4,422,897	-$81.07M	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.